Bactrim Regimen for Uncomplicated UTI
For an uncomplicated urinary tract infection in an adult with normal renal function, prescribe trimethoprim-sulfamethoxazole 160/800 mg (one double-strength tablet) twice daily for 3 days, but only if local resistance rates are known to be less than 20%. 1
Key Dosing Details
The standard regimen is:
- Dose: 160 mg trimethoprim/800 mg sulfamethoxazole (1 double-strength tablet)
- Frequency: Twice daily
- Duration: 3 days
This achieves clinical cure rates of 90-100% in the early post-treatment period and 79-90% at 30 days when organisms are susceptible 1.
Critical Resistance Consideration
The 20% resistance threshold is crucial. Studies demonstrate that when the infecting organism is resistant to TMP-SMX, clinical cure rates plummet from 84% to only 41% 1. This dramatic difference means you must know your local antibiogram before prescribing empirically.
- If local E. coli resistance to TMP-SMX exceeds 20%, choose nitrofurantoin instead (100 mg twice daily for 5 days) 1
- If the organism is known to be susceptible from prior culture, TMP-SMX remains highly effective regardless of local resistance patterns 1
Alternative Durations (Less Preferred)
While the guideline-recommended duration is 3 days, older studies examined other regimens:
- Single-dose therapy: 320 mg TMP/1600 mg SMX (2 double-strength tablets) as a single dose showed 87-93% cure rates 2, 3, 4, but 3-day regimens are more effective than single-dose for all antimicrobials tested 5
- 7-10 day courses: Used in older studies with similar efficacy to 3-day courses but significantly more adverse effects (24% vs 4%) 2
The 3-day regimen optimizes efficacy while minimizing adverse effects and collateral damage (antimicrobial resistance development) 1.
Important Safety Considerations
- Renal function: Peak levels occur 1-4 hours post-dose; half-lives are 10 hours for sulfamethoxazole and 8-10 hours for trimethoprim 6
- Renal impairment: Requires dose adjustment when creatinine clearance <30 mL/min 7
- Elderly patients: Higher risk of acute kidney injury (adjusted OR 1.72) and hyperkalemia (adjusted OR 2.27) compared to amoxicillin, particularly in those on renin-angiotensin system blockers 8
- Avoid in pregnancy - not addressed in these guidelines for uncomplicated cystitis 1
When NOT to Use TMP-SMX
Do not use empirically if:
- Local resistance rates ≥20% (use nitrofurantoin or fosfomycin instead) 1
- Patient is on renin-angiotensin system blockers plus spironolactone (18 additional cases of hyperkalemia per 1000 treated) 8
- Recent TMP-SMX use or known prior resistance 1
The evidence strongly supports the 3-day regimen as the optimal balance of efficacy, safety, and antimicrobial stewardship when resistance patterns permit its use.